NIH-funded research NIH-funded research

Centralized support for managing and analyzing diverse data types in drug discovery.

Official title: Data Management Core

Funded at Univ of North Carolina Chapel Hill · NIH-10974394 · Data updated 2026-11-12

This study is all about building a helpful system that makes it easier for researchers to share and work with data related to discovering new drugs, so they can collaborate better and make progress faster.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 19, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$136,738
NIH project number1U19NS138975-01
Project IDNIH-10974394 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals involved in or affected by conditions requiring analgesic treatments, such as chronic pain or back pain.

Less likely to help

Patients with conditions unrelated to analgesic treatments or those not involved in drug discovery processes may not receive direct benefits from this research.

What this research studies

This project focuses on creating a centralized Data Management Core (DMC) that will support the generation, management, and analysis of various data types related to drug discovery. The DMC will establish a robust infrastructure to facilitate collaboration among researchers, ensuring effective data harmonization, aggregation, and sharing. Led by an experienced team, the DMC aims to implement best practices in data management and provide essential tools and expertise throughout the research process.

Why it matters

Potential benefit: If successful, this research could enhance the efficiency and effectiveness of drug discovery processes, potentially leading to better treatment options for patients.

How similar studies have gone: Other research initiatives have successfully utilized centralized data management approaches to improve drug discovery outcomes, indicating that this methodology is both tested and promising.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Schnitzer, Mark J — Univ of North Carolina Chapel Hill
  • Study coordinator: Schnitzer, Mark J

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.